Benchmark Research Sacramento

Sacramento, California 95864

0 studies enrolling now · 5 studies all time

What they study most

Influenza, SARS-CoV-2, Smoking Cessation

Studies at this site

• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
• Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok — Completed
• Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid — Completed
• Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age — Completed